Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

Summary

This is an investigator initiated and conducted, multicentre, ambulance-delivered, prospective, randomised, open-label, blinded outcome (PROBE) study. EAST aims to evaluate the effects of pre-hospital levetiracetam and different head positions initiated in ambulance settings on the functional outcome of participants assessed at 90 days.

Timeline

Start

2025-04-30

Primary completion

2028-12-31

Completion

2029-12-31

Drugs

Indications